EBRO 2017

IASLC Lung Cancer Staging Project RPA on 6 609 SCLC treated 1990-2000 weight loss, comorbidities not included

Group Gender Disease PS Age Survival (med)

localized localized localized extended extended extended extended localized extended extended

0 1-2 1-2 0

<60 <65 ≥65 <65 ≥65

I

17 months

II

12 months

F

F M

0 0 1

III

10 months

<70

3-4 1 2-4

IV

≥70 6 months

Sculier J Thorac Oncol 2008